Findings aid antiviral drug discovery
Many viral infections, such as the common cold, cause mild illnesses that the body’s immune system eventually defeats. But when viruses cause severe disease, doctors have few options for effective treatment.
Studying mice with a variety of viral infections, scientists at Washington University School of Medicine in St. Louis have demonstrated a way to dial up the body’s innate immune defenses while simultaneously attacking a protein that many viruses rely on to replicate.
The findings, published Oct. 19 in Nature Immunology, reveal previously unknown weapons in the body’s antiviral immune arsenal and provide guidelines for designing drugs that could be effective against a broad range of viruses. The strategy involves enhancing the body’s interferon signaling system, long understood to be a vital part of antiviral defenses.
“We’ve discovered a new component of the interferon system,” said senior author Michael J. Holtzman, MD, the Selma and Herman Seldin Professor of Medicine. “It does something that other components don’t do, and it works on both sides of the fence: It dials up the body’s internal genes that fight viruses, and it attacks viral proteins directly.”
Holtzman and lead author Yong Zhang, PhD, an instructor in pulmonary medicine, suspect that the researchers’ one-two punch against the virus may explain the large difference in survival rates between control mice and mice genetically engineered to have increased signaling in their interferon systems.
When infected with encephalomyocarditis virus, which causes severe damage to vital organs including the brain, heart and pancreas, 97 percent of the genetically engineered mice survived, compared with none of the control mice. Even when the concentration of the injected virus was increased 100-fold, 82 percent of the genetically altered mice survived. And at 100-fold lower concentrations, all genetically engineered mice survived the infection, compared with only 25-28 percent of the control mice.
Holtzman pointed out that past research by other groups has shown that increasing the amount of interferon directly results in some improvements in fighting viruses, but not to the same extent as the current work. In addition, more modest improvements shown by other investigators usually are accompanied by autoimmune problems resulting from the chronically activated immune response. Despite the strong antiviral immune response seen in the new study, Holtzman and his colleagues reported no evidence of autoimmune disease in these mice.
The Latest on: Antiviral immune response
via Google News
The Latest on: Antiviral immune response
- Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2on May 28, 2020 at 8:14 pm
In this regard, treatments addressing the immunopathology of SARS-CoV-2 infection have become a major focus. Notably, while a rapid and well-coordinated immune response represents the first line of ...
- Ferritin heavy chain protein shows promise as a potential SARS-CoV-2 vaccine or antiviralon May 28, 2020 at 5:41 pm
A new study published on the online preprint server bioRxiv in May 2020 reports the construction and testing of a new ferritin-based antigen-bearing protein that has biological activity towards the ...
- First human trial of COVID-19 vaccine finds it is safe and induces rapid immune responseon May 22, 2020 at 10:23 am
A study of 108 adults finds that the vaccine produced neutralizing antibodies and T-cell response against SARS-CoV-2, but further research is needed to confirm whether the vaccine protects against ...
- New details regarding the immune response in COVID-19on May 22, 2020 at 7:53 am
The human immune system is reactive to more than just the viral protein on which researchers have focused to date. This is relevant for tests and potential vaccines.
- PGAM5-MAVS interaction regulates TBK1/ IRF3 dependent antiviral responseson May 20, 2020 at 2:16 am
IFNβ induces cellular antiviral defense mechanisms and thereby contributes to pathogen clearance. Accumulating evidence suggests that mitochondria constitute a crucial platform for the induction of ...
- Coronavirus vaccine from Moderna shows early promise of viral immune responseon May 18, 2020 at 11:22 am
An experimental vaccine from Moderna Inc. showed promising early signs that it can create an immune-system response in the body that could help fend off the n ...
- People Mount Strong Immune Responses to Coronavirus, Boding Well for a Vaccineon May 18, 2020 at 9:47 am
As the drive towards a vaccine against the new coronavirus accelerates, there's some good news: People with COVID-19 have robust immune responses against the virus, scientists say. The researchers ...
- Coronavirus Vaccine From Moderna Shows Early Signs of Viral Immune Responseon May 18, 2020 at 9:00 am
An experimental vaccine from the U.S. biotechnology company Moderna Inc. showed signs that it can create an immune-system response to fend off the new coronavirus, offering tentative hopes in the ...
- Vaccine from Moderna shows early promise with viral immune responseon May 18, 2020 at 5:11 am
The study was primarily designed to look at the safety of the shot and showed no major warning signs in a small phase 1 trial ...
- Good News for COVID-19 Vaccine: Immune System Shows Robust Response to SARS-CoV-2on May 18, 2020 at 5:00 am
Studying average COVID-19 cases found the immune system can recognize SARS-CoV-2 in multiple ways, with antibodies made in 100% of cases ...
via Bing News